Reginald L. Hardy - Jul 23, 2021 Form 4 Insider Report for Brickell Biotech, Inc. (FRTX)

Role
CHAIRMAN OF THE BOARD, Director
Signature
/s/ Christine G. Long, Attorney-in-Fact for Reginald L. Hardy (power of attorney previously filed)
Stock symbol
FRTX
Transactions as of
Jul 23, 2021
Transactions value $
$133,650
Form type
4
Date filed
7/27/2021, 04:43 PM
Previous filing
Jun 14, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $66.2K +100K +40.26% $0.66 348K Jul 23, 2021 Direct F1
transaction FRTX Common Stock Purchase $67.4K +100K +28.7% $0.67 448K Jul 26, 2021 Direct F2
holding FRTX Common Stock 9.26K Jul 23, 2021 By Spouse
holding FRTX Common Stock 21.8K Jul 23, 2021 By Spouse (spouse jointly owns with other Individual)
holding FRTX Common Stock 17.3K Jul 23, 2021 By Spouse as Trustee
holding FRTX Common Stock 266K Jul 23, 2021 By Self as General Partner
holding FRTX Common Stock 17.3K Jul 23, 2021 By Self as Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.66 to $0.6720 per share, resulting in a weighted average purchase price of $0.6623. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
F2 Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.671 to $0.678 per share, resulting in a weighted average purchase price of $0.6742. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.